NYU Langone Health: New Strategy Emerges for Vaccine Against Methicillin-Resistant Staphylococcal Aureus
July 01, 2020
July 01, 2020
NEW YORK, July 1 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.
The new vaccination strategy, developed by researchers at NYU Grossman School of Medicine, targets toxic molecule . . .
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.
The new vaccination strategy, developed by researchers at NYU Grossman School of Medicine, targets toxic molecule . . .